PT  - JOURNAL ARTICLE
AU  - Merola, Joseph F.
AU  - Armstrong, April W.
AU  - Saraiya, Ami
AU  - Latella, John
AU  - Garg, Amit
AU  - Callis Duffin, Kristina
AU  - Gottlieb, Alice B.
TI  - International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update
AID  - 10.3899/jrheum.160114
DP  - 2016 May 01
TA  - The Journal of Rheumatology
PG  - 959--960
VI  - 43
IP  - 5
4099  - http://www.jrheum.org/content/43/5/959.short
4100  - http://www.jrheum.org/content/43/5/959.full
SO  - J Rheumatol2016 May 01; 43
AB  - Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.